Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 118

1.

Strategies to obtain multiple recombinant modified vaccinia Ankara vectors. Applications to influenza vaccines.

Barbieri A, Panigada M, Soprana E, Di Mario G, Gubinelli F, Bernasconi V, Recagni M, Donatelli I, Castrucci MR, Siccardi AG.

J Virol Methods. 2018 Jan;251:7-14. doi: 10.1016/j.jviromet.2017.10.003. Epub 2017 Oct 4.

PMID:
28987424
2.

Immunogenicity of modified vaccinia virus Ankara expressing the hemagglutinin stalk domain of pandemic (H1N1) 2009 influenza virus.

Di Mario G, Soprana E, Gubinelli F, Panigada M, Facchini M, Fabiani C, Garulli B, Basileo M, Cassone A, Siccardi A, Donatelli I, Castrucci MR.

Pathog Glob Health. 2017 Mar;111(2):69-75. doi: 10.1080/20477724.2016.1275464. Epub 2017 Jan 12.

3.

Protective immunity against influenza in HLA-A2 transgenic mice by modified vaccinia virus Ankara vectored vaccines containing internal influenza proteins.

Di Mario G, Sciaraffia E, Facchini M, Gubinelli F, Soprana E, Panigada M, Bernasconi V, Garulli B, Siccardi A, Donatelli I, Castrucci MR.

Pathog Glob Health. 2017 Mar;111(2):76-82. doi: 10.1080/20477724.2016.1275465. Epub 2017 Jan 12.

4.

Human-Animal Interface: The Case for Influenza Interspecies Transmission.

Donatelli I, Castrucci MR, De Marco MA, Delogu M, Webster RG.

Adv Exp Med Biol. 2017;972:17-33. doi: 10.1007/5584_2016_136.

PMID:
27677275
5.

Influenza A(H7N7) Virus among Poultry Workers, Italy, 2013.

Puzelli S, Rizzo C, Fabiani C, Facchini M, Gaibani P, Landini MP, Gagliotti C, Moro ML, Rangoni R, Piccolomini LL, Finarelli AC, Tamba M, Rezza G, Declich S, Donatelli I, Castrucci MR.

Emerg Infect Dis. 2016 Aug;22(8):1512-3. doi: 10.3201/eid2208.160246. No abstract available.

6.

A heat-inactivated H7N3 vaccine induces cross-reactive cellular immunity in HLA-A2.1 transgenic mice.

Di Mario G, Garulli B, Sciaraffia E, Facchini M, Donatelli I, Castrucci MR.

Virol J. 2016 Mar 31;13:56. doi: 10.1186/s12985-016-0513-7.

7.

Generation of switched memory B cells in response to vaccination in Down syndrome children and their siblings.

Valentini D, Marcellini V, Bianchi S, Villani A, Facchini M, Donatelli I, Castrucci MR, Marasco E, Farroni C, Carsetti R.

Vaccine. 2015 Nov 27;33(48):6689-96. doi: 10.1016/j.vaccine.2015.10.083. Epub 2015 Oct 28.

8.

Human infection with highly pathogenic A(H7N7) avian influenza virus, Italy, 2013.

Puzelli S, Rossini G, Facchini M, Vaccari G, Di Trani L, Di Martino A, Gaibani P, Vocale C, Cattoli G, Bennett M, McCauley JW, Rezza G, Moro ML, Rangoni R, Finarelli AC, Landini MP, Castrucci MR, Donatelli I; Influenza Task Force.

Emerg Infect Dis. 2014 Oct;20(10):1745-9. doi: 10.3201/eid2010.140512.

9.

Prostaglandin A1 inhibits avian influenza virus replication at a postentry level: Effect on virus protein synthesis and NF-κB activity.

Carta S, La Frazia S, Donatelli I, Puzelli S, Rossi A, Santoro MG.

Prostaglandins Leukot Essent Fatty Acids. 2014 Dec;91(6):311-23. doi: 10.1016/j.plefa.2014.07.009. Epub 2014 Jul 24.

PMID:
25151089
10.

B-sides serologic markers of immunogenicity in kidney transplanted patients: report from 2012-2013 flu vaccination experience.

Rinaldi S, Cagigi A, Santilli V, Zotta F, di Martino A, Castrucci MR, Donatelli I, Poggi E, Piazza A, Campana A, Guzzo I, Villani A, Rossi P, Dello Strologo L, Palma P.

Transplantation. 2014 Aug 15;98(3):259-66. doi: 10.1097/TP.0000000000000209.

PMID:
24911036
11.
12.

Is there a relation between genetic or social groups of mallard ducks and the circulation of low pathogenic avian influenza viruses?

De Marco MA, Valentini A, Foni E, Savarese MC, Cotti C, Chiapponi C, Raffini E, Donatelli I, Delogu M.

Vet Microbiol. 2014 Jun 4;170(3-4):418-24. doi: 10.1016/j.vetmic.2014.03.001. Epub 2014 Mar 12.

PMID:
24690373
13.

Safety and immunogenicity of co-administered MF59-adjuvanted 2009 pandemic and plain 2009-10 seasonal influenza vaccines in rheumatoid arthritis patients on biologicals.

Milanetti F, Germano V, Nisini R, Donatelli I, Di Martino A, Facchini M, Ferlito C, Cappella A, Crialesi D, Caporuscio S, Biselli R, Rossi F, Salemi S, D'Amelio R.

Clin Exp Immunol. 2014 Jul;177(1):287-94. doi: 10.1111/cei.12292.

14.

Chlamydophila pneumoniae, Mycoplasma pneumoniae, and influenza in children with respiratory infections in Alexandria, Egypt.

Grassi T, Mancini F, Ciervo A, Vescio MF, Ghazal A, Ashour H, Saleh E, El Zalabani M, Donatelli I, El Sawaf G, Rezza G.

J Infect Dev Ctries. 2014 Mar 13;8(3):379-83. doi: 10.3855/jidc.4458.

15.

Vaccination for seasonal influenza in patients with cancer: recommendations of the Italian Society of Medical Oncology (AIOM).

Pedrazzoli P, Baldanti F, Donatelli I, Castrucci MR, Puglisi F, Silvestris N, Cinieri S; Italian Society of Medical Oncology.

Ann Oncol. 2014 Jun;25(6):1243-7. doi: 10.1093/annonc/mdu114. Epub 2014 Mar 11.

PMID:
24618150
16.

Modified vaccinia virus Ankara expressing the hemagglutinin of pandemic (H1N1) 2009 virus induces cross-protective immunity against Eurasian 'avian-like' H1N1 swine viruses in mice.

Castrucci MR, Facchini M, Di Mario G, Garulli B, Sciaraffia E, Meola M, Fabiani C, De Marco MA, Cordioli P, Siccardi A, Kawaoka Y, Donatelli I.

Influenza Other Respir Viruses. 2014 May;8(3):367-75. doi: 10.1111/irv.12221. Epub 2013 Dec 23.

17.

Antibody but not memory B-cell responses are tuned-down in vertically HIV-1 infected children and young individuals being vaccinated yearly against influenza.

Rinaldi S, Zangari P, Cotugno N, Manno EC, Brolatti N, Castrucci MR, Donatelli I, Rossi P, Palma P, Cagigi A.

Vaccine. 2014 Feb 3;32(6):657-63. doi: 10.1016/j.vaccine.2013.12.008. Epub 2013 Dec 13.

PMID:
24333344
18.

Premature immune senescence during HIV-1 vertical infection relates with response to influenza vaccination.

Cagigi A, Rinaldi S, Di Martino A, Manno EC, Zangari P, Aquilani A, Cotugno N, Nicolosi L, Villani A, Bernardi S, Donatelli I, Pahwa S, Rossi P, Palma P.

J Allergy Clin Immunol. 2014 Feb;133(2):592-4. doi: 10.1016/j.jaci.2013.10.003. Epub 2013 Nov 28. No abstract available.

PMID:
24290278
19.

Pandemic influenza A/H1N1pdm in Italy: age, risk and population susceptibility.

Merler S, Ajelli M, Camilloni B, Puzelli S, Bella A, Rota MC, Tozzi AE, Muraca M, Meledandri M, Iorio AM, Donatelli I, Rizzo C.

PLoS One. 2013 Oct 7;8(10):e74785. doi: 10.1371/journal.pone.0074785. eCollection 2013.

20.

Investigation of an imported case of Middle East Respiratory Syndrome Coronavirus (MERS-CoV) infection in Florence, Italy, May to June 2013.

Puzelli S, Azzi A, Santini MG, Di Martino A, Facchini M, Castrucci MR, Meola M, Arvia R, Corcioli F, Pierucci F, Baretti S, Bartoloni A, Bartolozzi D, de Martino M, Galli L, Pompa MG, Rezza G, Balocchini E, Donatelli I.

Euro Surveill. 2013 Aug 22;18(34). pii: 20564.

21.

Surveillance of human influenza A(H3N2) virus from 1999 to 2009 in southern Italy.

DE Donno A, Idolo A, Quattrocchi M, Zizza A, Gabutti G, Romano A, Grima P, Donatelli I, Guido M.

Epidemiol Infect. 2014 May;142(5):933-9. doi: 10.1017/S095026881300201X. Epub 2013 Aug 22.

PMID:
23967903
22.

Reassortment ability of the 2009 pandemic H1N1 influenza virus with circulating human and avian influenza viruses: public health risk implications.

Stincarelli M, Arvia R, De Marco MA, Clausi V, Corcioli F, Cotti C, Delogu M, Donatelli I, Azzi A, Giannecchini S.

Virus Res. 2013 Aug;175(2):151-4. doi: 10.1016/j.virusres.2013.04.012. Epub 2013 Apr 29.

PMID:
23639426
23.

Evidence of cross-reactive immunity to 2009 pandemic influenza A virus in workers seropositive to swine H1N1 influenza viruses circulating in Italy.

De Marco MA, Porru S, Cordioli P, Cesana BM, Moreno A, Calzoletti L, Bonfanti L, Boni A, Di Carlo AS, Arici C, Carta A, Castrucci MR, Donatelli I, Tomao P, Peri VM, Di Trani L, Vonesch N.

PLoS One. 2013;8(2):e57576. doi: 10.1371/journal.pone.0057576. Epub 2013 Feb 28.

24.

Serosurvey against H5 and H7 avian influenza viruses in Italian poultry workers.

Di Trani L, Porru S, Bonfanti L, Cordioli P, Cesana BM, Boni A, Di Carlo AS, Arici C, Donatelli I, Tomao P, Vonesch N, De Marco MA.

Avian Dis. 2012 Dec;56(4 Suppl):1068-71.

PMID:
23402138
25.

Influenza epidemiology in Italy two years after the 2009-2010 pandemic: need to improve vaccination coverage.

Gasparini R, Bonanni P, Amicizia D, Bella A, Donatelli I, Cristina ML, Panatto D, Lai PL.

Hum Vaccin Immunother. 2013 Mar;9(3):561-7. Epub 2013 Jan 4.

26.

Understanding the dynamics of seasonal influenza in Italy: incidence, transmissibility and population susceptibility in a 9-year period.

Lunelli A, Rizzo C, Puzelli S, Bella A, Montomoli E, Rota MC, Donatelli I, Pugliese A.

Influenza Other Respir Viruses. 2013 May;7(3):286-95. doi: 10.1111/j.1750-2659.2012.00388.x. Epub 2012 Jun 14.

27.

Monitoring the susceptibility to oseltamivir of Influenza A(H1N1) 2009 virus by nested-PCR and pyrosequencing during the pandemic and in the season 2010-2011.

Arvia R, Corcioli F, Simi L, Orlando C, De Santis R, Facchini M, Donatelli I, Azzi A.

J Virol Methods. 2012 Sep;184(1-2):113-6. doi: 10.1016/j.jviromet.2012.05.018. Epub 2012 May 29.

PMID:
22659066
28.

Estimating pandemic vaccine effectiveness in two Italian regions using the screening method, 2009-2010.

Seyler T, Bella A, Puzelli S, Donatelli I, Rizzo C; screening method working group.

Vaccine. 2012 Jan 5;30(2):109-11. doi: 10.1016/j.vaccine.2011.11.013. Epub 2011 Nov 17.

PMID:
22100893
29.

Report of two cases of influenza virus A/H1N1v and B co-infection during the 2010/2011 epidemics in the Italian Veneto Region.

Calistri A, Salata C, Cosentino M, Asnicar S, Franchin E, Cusinato R, Pacenti M, Donatelli I, Palù G.

Virol J. 2011 Nov 3;8:502. doi: 10.1186/1743-422X-8-502.

30.

Surveillance of hospitalised patients with influenza-like illness during pandemic influenza A(H1N1) season in Sicily, April 2009-December 2010.

Tramuto F, Maida CM, Bonura F, Perna AM, Puzelli S, De Marco MA, Donatelli I, Aprea L, Firenze A, Arcadipane A, Palazzo U, Vitale F.

Euro Surveill. 2011 Sep 1;16(35). pii: 19957.

31.

Packaging signals in the 5'-ends of influenza virus PA, PB1, and PB2 genes as potential targets to develop nucleic-acid based antiviral molecules.

Giannecchini S, Wise HM, Digard P, Clausi V, Del Poggetto E, Vesco L, Puzelli S, Donatelli I, Azzi A.

Antiviral Res. 2011 Oct;92(1):64-72. doi: 10.1016/j.antiviral.2011.06.013. Epub 2011 Jun 29.

PMID:
21741410
32.

Evaluation of the antiviral drug susceptibility of influenza viruses in Italy from 2004/05 to 2009/10 epidemics and from the recent 2009 pandemic.

Puzelli S, Facchini M, Di Martino A, Fabiani C, Lackenby A, Zambon M, Donatelli I.

Antiviral Res. 2011 Jun;90(3):205-12. doi: 10.1016/j.antiviral.2011.04.003. Epub 2011 Apr 14.

PMID:
21514326
33.

Molecular surveillance of pandemic influenza A(H1N1) viruses circulating in Italy from May 2009 to February 2010: association between haemagglutinin mutations and clinical outcome.

Puzelli S, Facchini M, De Marco MA, Palmieri A, Spagnolo D, Boros S, Corcioli F, Trotta D, Bagnarelli P, Azzi A, Cassone A, Rezza G, Pompa MG, Oleari F, Donatelli I; Influnet Surveillance Group for Pandemic A(H1N1) 2009 Influenza Virus in Italy.

Euro Surveill. 2010 Oct 28;15(43). pii: 19696.

34.

Molecular adaptation of an H7N3 wild duck influenza virus following experimental multiple passages in quail and turkey.

Giannecchini S, Clausi V, Di Trani L, Falcone E, Terregino C, Toffan A, Cilloni F, Matrosovich M, Gambaryan AS, Bovin NV, Delogu M, Capua I, Donatelli I, Azzi A.

Virology. 2010 Dec 20;408(2):167-73. doi: 10.1016/j.virol.2010.09.011. Epub 2010 Oct 14.

35.

An influenza B outbreak during the 2007/2008 winter among appropriately immunized elderly people living in a nursing home.

Camilloni B, Neri M, Lepri E, Basileo M, Sigismondi N, Puzelli S, Donatelli I, Iorio AM.

Vaccine. 2010 Nov 3;28(47):7536-41. doi: 10.1016/j.vaccine.2010.08.064. Epub 2010 Sep 21.

PMID:
20846530
36.

Can preening contribute to influenza A virus infection in wild waterbirds?

Delogu M, De Marco MA, Di Trani L, Raffini E, Cotti C, Puzelli S, Ostanello F, Webster RG, Cassone A, Donatelli I.

PLoS One. 2010 Jun 25;5(6):e11315. doi: 10.1371/journal.pone.0011315.

37.

First case in Italy of acquired resistance to oseltamivir in an immunocompromised patient with influenza A/H1N1v infection.

Campanini G, Piralla A, Rovida F, Puzelli S, Facchini M, Locatelli F, Minoli L, Percivalle E, Donatelli I, Baldanti F; Surveillance Group for New Influenza A/H1N1v Investigation in Italy.

J Clin Virol. 2010 Jul;48(3):220-2. doi: 10.1016/j.jcv.2010.03.027. Epub 2010 May 5.

PMID:
20447860
38.

Transmission of hemagglutinin D222G mutant strain of pandemic (H1N1) 2009 virus.

Puzelli S, Facchini M, Spagnolo D, De Marco MA, Calzoletti L, Zanetti A, Fumagalli R, Tanzi ML, Cassone A, Rezza G, Donatelli I; Surveillance Group for Pandemic A H1N1 2009 Influenza Virus in Italy.

Emerg Infect Dis. 2010 May;16(5):863-5. doi: 10.3201/eid1605.091815.

39.

Cardiac tamponade and heart failure due to myopericarditis as a presentation of infection with the pandemic H1N1 2009 influenza A virus.

Puzelli S, Buonaguro FM, Facchini M, Palmieri A, Calzoletti L, De Marco MA, Arace P, de Campora E, Esposito C, Cassone A, Rezza G, Donatelli I; Surveillance Group for Pandemic H1N1 2009 Influenza Virus in Italy; Campania H1N1 Task Force.

J Clin Microbiol. 2010 Jun;48(6):2298-300. doi: 10.1128/JCM.00418-10. Epub 2010 Apr 14.

40.

Bovine lactoferrin inhibits influenza A virus induced programmed cell death in vitro.

Pietrantoni A, Dofrelli E, Tinari A, Ammendolia MG, Puzelli S, Fabiani C, Donatelli I, Superti F.

Biometals. 2010 Jun;23(3):465-75. doi: 10.1007/s10534-010-9323-3. Epub 2010 Mar 16.

PMID:
20232110
41.

Viral causes of influenza-like illness: Insight from a study during the winters 2004-2007.

Puzelli S, Valdarchi C, Ciotti M, Dorrucci M, Farchi F, Babakir-Mina M, Perno CF, Donatelli I, Rezza G; Italian ARI Study Group.

J Med Virol. 2009 Dec;81(12):2066-71. doi: 10.1002/jmv.21610.

PMID:
19856468
42.

Influenza vaccine administration in rheumatoid arthritis patients under treatment with TNFalpha blockers: safety and immunogenicity.

Salemi S, Picchianti-Diamanti A, Germano V, Donatelli I, Di Martino A, Facchini M, Nisini R, Biselli R, Ferlito C, Podestà E, Cappella A, Milanetti F, Rossi F, Amodeo R, Tabacco F, Di Rosa R, Laganà B, D Amelio R.

Clin Immunol. 2010 Feb;134(2):113-20. doi: 10.1016/j.clim.2009.09.014. Epub 2009 Oct 21.

PMID:
19846344
43.

Human monoclonal antibodies in single chain fragment variable format with potent neutralization activity against influenza virus H5N1.

Ascione A, Capecchi B, Campitelli L, Imperiale V, Flego M, Zamboni S, Gellini M, Alberini I, Pittiglio E, Donatelli I, Temperton NJ, Cianfriglia M.

Antiviral Res. 2009 Sep;83(3):238-44. doi: 10.1016/j.antiviral.2009.05.005. Epub 2009 May 27.

PMID:
19481117
44.

A phase I clinical trial of a PER.C6 cell grown influenza H7 virus vaccine.

Cox RJ, Madhun AS, Hauge S, Sjursen H, Major D, Kuhne M, Höschler K, Saville M, Vogel FR, Barclay W, Donatelli I, Zambon M, Wood J, Haaheim LR.

Vaccine. 2009 Mar 18;27(13):1889-97. doi: 10.1016/j.vaccine.2009.01.116. Epub 2009 Feb 2.

PMID:
19368768
45.

Molecular analysis of avian H7 influenza viruses circulating in Eurasia in 1999-2005: detection of multiple reassortant virus genotypes.

Campitelli L, Di Martino A, Spagnolo D, Smith GJ, Di Trani L, Facchini M, De Marco MA, Foni E, Chiapponi C, Martin AM, Chen H, Guan Y, Delogu M, Donatelli I.

J Gen Virol. 2008 Jan;89(Pt 1):48-59.

PMID:
18089728
46.

Amino acid changes in the attachment G glycoprotein of human respiratory syncytial viruses (subgroup A) isolated in Italy over several epidemics (1997-2006).

Montieri S, Puzelli S, Ciccozzi M, Calzoletti L, Di Martino A, Milia MG, Rossi A, Piro F, Rezza G, Donatelli I.

J Med Virol. 2007 Dec;79(12):1935-42.

PMID:
17935190
47.

Characterization of human H1N1 influenza virus variants selected in vitro with zanamivir in the presence of sialic acid-containing molecules.

Giannecchini S, Campitelli L, Bandini G, Donatelli I, Azzi A.

Virus Res. 2007 Nov;129(2):241-5. Epub 2007 Sep 4.

PMID:
17765996
48.

Generation of candidate human influenza vaccine strains in cell culture - rehearsing the European response to an H7N1 pandemic threat.

Whiteley A, Major D, Legastelois I, Campitelli L, Donatelli I, Thompson CI, Zambon MC, Wood JM, Barclay WS.

Influenza Other Respir Viruses. 2007 Jul;1(4):157-66. doi: 10.1111/j.1750-2659.2007.00022.x.

49.

Characterization of low-pathogenic H5 subtype influenza viruses from Eurasia: implications for the origin of highly pathogenic H5N1 viruses.

Duan L, Campitelli L, Fan XH, Leung YH, Vijaykrishna D, Zhang JX, Donatelli I, Delogu M, Li KS, Foni E, Chiapponi C, Wu WL, Kai H, Webster RG, Shortridge KF, Peiris JS, Smith GJ, Chen H, Guan Y.

J Virol. 2007 Jul;81(14):7529-39. Epub 2007 May 16.

50.

Evolutionary analysis of HA and NS1 genes of H5N1 influenza viruses in 2004-2005 epidemics.

Ciccozzi M, Montieri S, Facchini M, Rezza G, Donatelli I, Campitelli L.

Avian Dis. 2007 Mar;51(1 Suppl):455-60.

PMID:
17494606

Supplemental Content

Loading ...
Support Center